Nutex Health, Inc. (NUTX) - Stock Analysis
Last updated: Apr 5, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠High margins ⢠Strong FCF ⢠Elevated leverage NUTX delivers strong operating profitability and free cash flow with modest market multiples, but meaningful debt, large receivables and a big noncontrolling interest materially constrain equity upside.
Price Behavior
Key Price Behavior Insights: ⢠Short-term uptrend ⢠Resistance-capped rallies ⢠Volatile price swings Support Level: $87â$89 Resistance Level: $103â$106 NUTX has rallied into a short-term uptrend over the last month with price now above the last-month moving average but faces near-term resistance at $103â$106 and support at $87â$89 amid elevated volatility.
Sentiment & News
Key News Insights: ⢠Strong full-year ⢠Q4 true-up ⢠Legal scrutiny Nutex Health posted sharply improved FY25 results but disclosed a $55M Q4 true-up tied to arbitration ineligibility that coincided with a stock drop and prompted multiple investor investigations.
AI Summary
NUTX's investment thesis has shifted from an execution/margin story to a binary riskâreward tied to arbitration revenue quality and disclosure transparencyâif management can materially and verifiably stabilize arbitration recognition and settle disclosure/legal uncertainty, shares likely reârate from depressed multiples, but further adverse determinations or restatements would rapidly destroy investor confidence despite strong 2025 cash generation.
Description
Nutex Health, Inc. is a Houston-based, technology-enabled healthcare services company with two operating segments: a Hospital division that owns and operates 21 facilities across eight states, including micro-hospitals, specialty hospitals and hospital outpatient departments; and a Population Health Management division that manages provider networks and delivers management and administrative support to affiliated hospitals and physician groups. The population health unit also maintains a proprietary cloud platform that consolidates clinical and administrative data from multiple systems to provide a comprehensive view of patients and providers and to support care delivery.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 31 | Jan 7 | NUTX | Nutex Health, Inc. | Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring. | Closed | +8.2% |